"Methods And Use For Bioengineering Enucleated Cells" in Patent Application Approval Process (USPTO 20230103075).
In: Stem Cell Week, 2023-04-17, S. 64-64
serialPeriodical
Zugriff:
A method of delivering an enucleated cell to a subject, the method comprising: administering to the subject an enucleated cell, wherein the enucleated cell is genetically engineered to evade recognition by the immune system by depleting the enucleated cell of one or more immune recognition molecules. Keywords: Bioengineering; Biotechnology; Cancer; Cancer Gene Therapy; Chemokines; Cytokines; Drugs and Therapies; Engineering; Gene Therapy; Genetic Engineering; Genetics; Health and Medicine; Inflammation; Intercellular Signaling Peptides and Proteins; Oncology; Patent Application; Peptides; Pharmaceuticals; Proteins; Proteomics; Stem Cell Research; Technology; Therapeutics; Therapy; Viral RNA EN Bioengineering Biotechnology Cancer Cancer Gene Therapy Chemokines Cytokines Drugs and Therapies Engineering Gene Therapy Genetic Engineering Genetics Health and Medicine Inflammation Intercellular Signaling Peptides and Proteins Oncology Patent Application Peptides Pharmaceuticals Proteins Proteomics Stem Cell Research Technology Therapeutics Therapy Viral RNA 64 64 1 04/17/23 20230417 NES 230417 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- A patent application by the inventors Klemke, Richard (La Jolla, CA, US); Pi, Willie (La Jolla, CA, US); Wang, Huawei (La Jolla, CA, US), filed on August 3, 2022, was made available online on March 30, 2023, according to news reporting originating from Washington, D.C., by NewsRx correspondents. [Extracted from the article]
Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Methods And Use For Bioengineering Enucleated Cells" in Patent Application Approval Process (USPTO 20230103075).
|
---|---|
Zeitschrift: | Stem Cell Week, 2023-04-17, S. 64-64 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1360 (print) |
Sonstiges: |
|